相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
S. De Vita et al.
ARTHRITIS AND RHEUMATISM (2012)
Genetic Determinants in Hepatitis C Virus-Associated Mixed Cryoglobulinemia: Role of Polymorphic Variants of BAFF Promoter and Fcγ Receptors
Laura Gragnani et al.
ARTHRITIS AND RHEUMATISM (2011)
Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type
Marc Ittah et al.
JOURNAL OF INNATE IMMUNITY (2011)
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
Chris J. Hedegaard et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
Franco Dammacco et al.
BLOOD (2010)
Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies
Ajax M. Atta et al.
MICROBIAL PATHOGENESIS (2010)
Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma
Anne J. Novak et al.
CANCER RESEARCH (2009)
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection
G. Tarantino et al.
JOURNAL OF VIRAL HEPATITIS (2009)
BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
Valeriya Zarkhin et al.
TRANSPLANTATION (2009)
The Evolutionary Dynamics of a Rapidly Mutating Virus within and between Hosts: The Case of Hepatitis C Virus
Fabio Luciani et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Direct B cell stimulation by dendritic cells in a mouse model of lupus
Suigui Wan et al.
ARTHRITIS AND RHEUMATISM (2008)
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?
Carlo Giannini et al.
BLOOD (2008)
Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
Marc Ittah et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
BAFF is a biological response marker to IFN-β treatment in multiple sclerosis
Kaushal S. Gandhi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)
Substitution rate of the hepatitis B virus surface gene
H. L. Zaaijer et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b
T. De Blasi et al.
INFECTION (2008)
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Frederic Lavie et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Hepatitis C virus-associated B-cell proliferation - the role of serum B lymphocyte stimulator (BLyS/BAFF)
D. Sene et al.
RHEUMATOLOGY (2007)
Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity
E. Toubi et al.
JOURNAL OF AUTOIMMUNITY (2006)
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders
AJ Novak et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
Marc Ittah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Vasculitic complications of interferon-a treatment for chronic hepatitis C virus infection: case report and review of the literature
W Beuthien et al.
CLINICAL RHEUMATOLOGY (2005)
BAFF augments certain Th1-associated inflammatory responses
APR Sutherland et al.
JOURNAL OF IMMUNOLOGY (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
R Lesley et al.
IMMUNITY (2004)
Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa
D Batisse et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
M Thien et al.
IMMUNITY (2004)
Analysis on the association of human BLYS (BAFF TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis
A Kawasaki et al.
GENES AND IMMUNITY (2002)
Pathogenesis and natural history of osteonecrosis
Y Assouline-Dayan et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Th1/Th2 cytokine imbalance in patients with Sjogren syndrome secondary to hepatitis C virus infection
M Ramos-Casals et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy
F Dammacco et al.
SEMINARS IN LIVER DISEASE (2000)
分享论文
